Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

Adv Ther. 2021 Aug;38(8):4598. doi: 10.1007/s12325-021-01837-0.

Authors

Juanzhi Fang¹, Stephanie Korrer², Jonathan C Johnson², Mark A Cheadle³, Roshani Shah³, Matias L Ferraris⁴, Cristina Lopez-Lopez⁴

Affiliations

¹ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. [email protected].
² Optum, Eden Prairie, MN, USA.
³ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
⁴ Novartis Pharma AG, Basel, Switzerland.

PMID: 34273094
DOI: 10.1007/s12325-021-01837-0

No abstract available

Publication types

Published Erratum